400-008-0030
咨詢熱線400-008-0030
中國化學制藥股份有限公司(中國臺灣)
China Chemical Pharmaceutical Co., Ltd.（Taiwan, China）
中國化學制藥股份有限公司成立于1952年，致力于藥品及保健食品、特醫食品的創新、研發、生產、服務。中國化學制藥在中國臺灣有6家子公司、中國大陸有2家全資子公司，股票代碼：中化1701.
中國化學制藥股份有限公司全資子公司--臺灣中化健康生技有限公司，負責山東哈維藥業的投資業務。臺灣中化致力于克弗爾肽全球推廣的健康事業，公司團隊經過二十年多年研究，發現并驗證克弗爾肽在心腦血管、骨科等多領域內具有很好的臨床效果。克服了傳統開菲爾粒菌種少，勝肽含量極少的難題，通過專利工藝，成功培育出克弗爾肽，填補了國際空白.其技術“新穎抗高血壓肽及其用途”，獲得包括中國、美國、德國、法國、瑞士等在內的10幾個國家和地區的專利。
Founded in 1952, China Chemical Pharmaceutical Co., Ltd. is committed to the innovation, R & D, production and service of medicine, health food and special medical food. Sinochem has 6 subsidiaries in Taiwan and 2 wholly-owned subsidiaries in mainland China, stock code: Sinochem 1701
Taiwan Sinochem Health Biotechnology Co., Ltd. is a wholly-owned subsidiary of China Chemical Pharmaceutical Co., Ltd., which is responsible for the investment business of Shandong Harvey pharmaceutical industry. Taiwan Sinochem is committed to the global promotion of Kefir Peptide. After more than 20 years of research, the team of the company found and verified thatKefir Peptide has a good clinical effect on cardio cerebrovascular, orthopedic diseases and other fields. The invention overcomes the problem that the traditional kefir granules have few strains and few peptide contents, and successfully cultivates Kefir Peptide through patented technology, which fills the international gap. Its technology "Novel Anti-hypertensive Peptide and its Application" has obtained patents from more than 10 countries and regions including China, the United States, Germany, France, Switzerland, etc.
北京華泰科醫藥科技有限公司
Beijing Huataike Pharmaceutical Technology Co., Ltd.
北京華泰科醫藥科技有限公司成立于2013年1月，公司坐落于北京市國貿CBD商務區，是集藥品研發和銷售為一體的高新技術企業。北京華泰科醫藥具有完善的國內臨床銷售網絡，覆蓋全國3000多家二級以上醫院和6000多家一級醫院，產品涉及心腦血管、糖尿病、骨科、婦科、生殖、腫瘤、腎病等多個科室。
公司與國內外多家院校展開合作，進行藥品和特醫食品的研發工作，取得了多項研究成果，得到了醫學界高度好評。
Beijing Huataike Pharmaceutical Technology Co., Ltd. founded in January 2013, the company is located in the CBD of International Trade Center of Beijing. It is a high-tech enterprise integrating drug R & D and sales. Beijing Huatai Pharmaceutical Co., Ltd. has a complete domestic clinical sales network, covering more than 3000 Level-2 hospitals and more than 6000 Level-1 hospitals across the country. Its products involve cardio cerebrovascular, diabetes, orthopedics, gynecology, reproduction, tumor, kidney disease and other departments.
The company cooperates with many universities at home and abroad to carry out the research and development of medicine and special medical food, and has achieved many research results, which has been highly praised by the medical community.
技術支持：厚德網絡
